potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet [K-Phos Neutral]
RxNorm concept 1251241, branded drug (sbd). Prescribable name: K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet.
- RxCUI
- 1251241
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1251241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
K+ phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet [K-Phos Neutral]; K-Phos Neutral (phosphorus 250 MG / sodium 298 MG (13 MEQ) / potassium 45 MG (1.1 MEQ)) Oral Tablet; K-Phos Neutral (potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG) Oral Tablet; Pot phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet [K-Phos Neutral]
Related concepts
- potassium phosphate 155 MG (SCDC, consists of)
- sodium phosphate, dibasic 852 MG (SCDC, consists of)
- sodium phosphate, monobasic 130 MG (SCDC, consists of)
- potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG [K-Phos Neutral] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- K-Phos Neutral (BN, has ingredient)
- potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1251241 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1251241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1251241. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.